vs

Side-by-side financial comparison of CPI Card Group Inc. (PMTS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

CPI Card Group Inc. is the larger business by last-quarter revenue ($153.1M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp). CPI Card Group Inc. runs the higher net margin — 4.8% vs -38.1%, a 42.9% gap on every dollar of revenue. On growth, CPI Card Group Inc. posted the faster year-over-year revenue change (22.3% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 16.9%).

CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

PMTS vs PRCT — Head-to-Head

Bigger by revenue
PMTS
PMTS
1.8× larger
PMTS
$153.1M
$83.1M
PRCT
Growing faster (revenue YoY)
PMTS
PMTS
+2.2% gap
PMTS
22.3%
20.2%
PRCT
Higher net margin
PMTS
PMTS
42.9% more per $
PMTS
4.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
16.9%
PMTS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PMTS
PMTS
PRCT
PRCT
Revenue
$153.1M
$83.1M
Net Profit
$7.3M
$-31.6M
Gross Margin
31.5%
64.9%
Operating Margin
12.0%
-4.1%
Net Margin
4.8%
-38.1%
Revenue YoY
22.3%
20.2%
Net Profit YoY
8.5%
-27.9%
EPS (diluted)
$0.62
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PMTS
PMTS
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$153.1M
$76.4M
Q3 25
$138.0M
$83.3M
Q2 25
$129.8M
$79.2M
Q1 25
$122.8M
$69.2M
Q4 24
$125.1M
$68.2M
Q3 24
$124.8M
$58.4M
Q2 24
$118.8M
$53.4M
Net Profit
PMTS
PMTS
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$7.3M
$-29.8M
Q3 25
$2.3M
$-21.4M
Q2 25
$518.0K
$-19.6M
Q1 25
$4.8M
$-24.7M
Q4 24
$6.8M
$-18.9M
Q3 24
$1.3M
$-21.0M
Q2 24
$6.0M
$-25.6M
Gross Margin
PMTS
PMTS
PRCT
PRCT
Q1 26
64.9%
Q4 25
31.5%
60.6%
Q3 25
29.7%
64.8%
Q2 25
30.9%
65.4%
Q1 25
33.2%
63.9%
Q4 24
34.1%
64.0%
Q3 24
35.8%
63.2%
Q2 24
35.7%
59.0%
Operating Margin
PMTS
PMTS
PRCT
PRCT
Q1 26
-4.1%
Q4 25
12.0%
-40.6%
Q3 25
9.4%
-27.8%
Q2 25
7.3%
-28.0%
Q1 25
11.5%
-39.7%
Q4 24
12.7%
-28.9%
Q3 24
14.3%
-38.4%
Q2 24
12.5%
-50.3%
Net Margin
PMTS
PMTS
PRCT
PRCT
Q1 26
-38.1%
Q4 25
4.8%
-39.1%
Q3 25
1.7%
-25.7%
Q2 25
0.4%
-24.7%
Q1 25
3.9%
-35.8%
Q4 24
5.4%
-27.6%
Q3 24
1.0%
-35.9%
Q2 24
5.1%
-48.0%
EPS (diluted)
PMTS
PMTS
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.62
$-0.54
Q3 25
$0.19
$-0.38
Q2 25
$0.04
$-0.35
Q1 25
$0.40
$-0.45
Q4 24
$0.56
$-0.34
Q3 24
$0.11
$-0.40
Q2 24
$0.51
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PMTS
PMTS
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$21.7M
$245.6M
Total DebtLower is stronger
$286.7M
$51.7M
Stockholders' EquityBook value
$-17.3M
$347.7M
Total Assets
$403.2M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PMTS
PMTS
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$21.7M
$286.5M
Q3 25
$16.0M
$294.3M
Q2 25
$17.1M
$302.7M
Q1 25
$31.5M
$316.2M
Q4 24
$33.5M
$333.7M
Q3 24
$14.7M
$196.8M
Q2 24
$7.5M
$214.1M
Total Debt
PMTS
PMTS
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$286.7M
$51.6M
Q3 25
$308.4M
$51.6M
Q2 25
$310.9M
$51.5M
Q1 25
$280.7M
$51.5M
Q4 24
$280.4M
$51.5M
Q3 24
$280.2M
$51.4M
Q2 24
$269.7M
$51.4M
Stockholders' Equity
PMTS
PMTS
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$-17.3M
$365.9M
Q3 25
$-25.7M
$380.3M
Q2 25
$-29.0M
$385.8M
Q1 25
$-29.7M
$389.2M
Q4 24
$-35.6M
$402.2M
Q3 24
$-42.8M
$241.2M
Q2 24
$-44.6M
$251.8M
Total Assets
PMTS
PMTS
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$403.2M
$508.1M
Q3 25
$407.1M
$511.5M
Q2 25
$399.8M
$513.1M
Q1 25
$351.9M
$519.4M
Q4 24
$349.7M
$534.0M
Q3 24
$342.3M
$374.1M
Q2 24
$321.4M
$374.4M
Debt / Equity
PMTS
PMTS
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PMTS
PMTS
PRCT
PRCT
Operating Cash FlowLast quarter
$39.6M
Free Cash FlowOCF − Capex
$35.2M
FCF MarginFCF / Revenue
23.0%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
5.39×
TTM Free Cash FlowTrailing 4 quarters
$41.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PMTS
PMTS
PRCT
PRCT
Q1 26
Q4 25
$39.6M
$-10.3M
Q3 25
$10.0M
$-6.6M
Q2 25
$4.3M
$-15.0M
Q1 25
$5.6M
$-17.0M
Q4 24
$26.7M
$-32.4M
Q3 24
$12.5M
$-18.8M
Q2 24
$-4.8M
$-15.7M
Free Cash Flow
PMTS
PMTS
PRCT
PRCT
Q1 26
Q4 25
$35.2M
$-12.2M
Q3 25
$5.3M
$-9.5M
Q2 25
$533.0K
$-17.8M
Q1 25
$292.0K
$-18.8M
Q4 24
$21.6M
$-33.6M
Q3 24
$11.1M
$-19.0M
Q2 24
$-6.0M
$-16.8M
FCF Margin
PMTS
PMTS
PRCT
PRCT
Q1 26
Q4 25
23.0%
-15.9%
Q3 25
3.8%
-11.4%
Q2 25
0.4%
-22.5%
Q1 25
0.2%
-27.2%
Q4 24
17.3%
-49.2%
Q3 24
8.9%
-32.6%
Q2 24
-5.0%
-31.4%
Capex Intensity
PMTS
PMTS
PRCT
PRCT
Q1 26
Q4 25
2.9%
2.4%
Q3 25
3.4%
3.4%
Q2 25
2.9%
3.5%
Q1 25
4.3%
2.7%
Q4 24
4.0%
1.7%
Q3 24
1.2%
0.4%
Q2 24
1.0%
2.0%
Cash Conversion
PMTS
PMTS
PRCT
PRCT
Q1 26
Q4 25
5.39×
Q3 25
4.32×
Q2 25
8.39×
Q1 25
1.17×
Q4 24
3.94×
Q3 24
9.70×
Q2 24
-0.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PMTS
PMTS

US Debit And Credit$128.9M84%
US Prepaid Debit$24.4M16%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons